Cargando…
Multiple treatment modalities for brain metastasis in patients with EGFR-mutant non-small-cell lung cancer
BACKGROUND: There are many controversies concerning the best management of epidermal growth factor receptor (EGFR)-mutant non-small-cell lung cancer (NSCLC) patients with brain metastases (BMs). The use of upfront EGFR tyrosine kinase inhibitors (TKIs) and the withholding of local therapies or upfro...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907894/ https://www.ncbi.nlm.nih.gov/pubmed/29713183 http://dx.doi.org/10.2147/OTT.S156570 |